SitesBLAST
Comparing WP_101588932.1 NCBI__GCF_900169175.1:WP_101588932.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 4 hits to proteins with known functional sites (download)
Q9R0W2 Solute carrier family 22 member 2; Organic cation transporter 2; rOCT2 from Rattus norvegicus (Rat) (see paper)
29% identity, 27% coverage: 71:204/489 of query aligns to 154:284/555 of Q9R0W2
Sites not aligning to the query:
- 451 Involved in recognition of organic cations and participates in structural changes that occur during translocation of organic cations; C→M: Transport activity strongly reduced.
O15244 Solute carrier family 22 member 2; Organic cation transporter 2; hOCT2 from Homo sapiens (Human) (see 8 papers)
29% identity, 22% coverage: 71:179/489 of query aligns to 154:251/555 of O15244
- M165 (≠ I85) to I: lower Vmax for MPP(+) transport; no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs8177507
- Y169 (≠ H89) mutation to F: No change in TEA uptake.
- T201 (≠ E121) to M: in dbSNP:rs145450955
- Y241 (≠ T169) mutation to F: Slight decrease in TEA uptake. No change in tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-362. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-362 and F-377.
Sites not aligning to the query:
- 54 P → S: in dbSNP:rs8177504
- 73 Y→F: No change in TEA uptake.
- 92 Y→F: No change in TEA uptake.
- 128 Y→F: No change in TEA uptake.
- 257 Y→F: No change in TEA uptake.
- 270 S → A: decreased Ki value for TBA inhibition of MPP(+); no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs316019
- 279 Y→F: No change in TEA uptake.
- 280 Y→F: No change in TEA uptake.
- 284 P→A: Decreased TEA and metformin uptake. Decreased tyrosine phosphorylation.
- 284:288 Proline-rich sequence
- 286 S→A: No change in TEA and metformin uptake. No change in tyrosine phosphorylation.
- 287 P→A: Decreased TEA and metformin uptake. Decreased tyrosine phosphorylation.
- 362 Y→F: Decreased TEA uptake and YES1-mediated tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-241. Strong decrease in TEA uptake; when associated with F-377. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-241 and F-377.
- 377 Y→F: Slight decrease in TEA uptake. No change in tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-362. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-241 and F-362.
- 400 R → C: lower Vmax and reduced Ki value for TBA inhibition of MPP(+); lower transport efficiency (Vmax/Km) and clearance of cyclo(his-pro); no change in transport efficiency (Vmax/Km) and clearance of salsolinol; dbSNP:rs8177516
- 432 K → Q: lower Km value for MPP(+) and reduced Ki value for TBA inhibition of MPP; no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs8177517
- 458 Y→F: No change in TEA uptake.
- 544 Y→F: No change in TEA uptake.
Q8MJI6 Solute carrier family 22 member 2; Organic cation transporter 2 from Oryctolagus cuniculus (Rabbit) (see paper)
28% identity, 22% coverage: 71:179/489 of query aligns to 153:250/554 of Q8MJI6
Sites not aligning to the query:
- 71 N→Q: Higher affinity for TEA. Loss of plasma membrane localization; when associated with Q-76. Loss of plasma membrane localization; when associated with Q-112. Loss of plasma membrane localization; when associated with Q-76 and Q-112.
- 96 N→Q: Higher affinity for TEA and lower Vmax.
- 112 N→Q: Higher affinity for TEA, lower Vmax and loss of plasma membrane localization.
8et9A Cryo-em structure of the organic cation transporter 2 in complex with 1-methyl-4-phenylpyridinium (see paper)
27% identity, 29% coverage: 40:179/489 of query aligns to 122:249/517 of 8et9A
Sites not aligning to the query:
Query Sequence
>WP_101588932.1 NCBI__GCF_900169175.1:WP_101588932.1
MRGTVTAASAAEPSTARGPFRGKQRVLASAFVGTTIEWYDFYLYGTAAALVFNVQFFPMD
SELGSLLASFATLAVGFFARPLGGIIAGHLGDRVGRKALLVVSLVTMGIASTLIGLMPTY
EAIGWWAAVGLVVLRIFQGLSAGAEWGGSALLSVEHAPVGSRGLFGSFTQIGSAAGMLLA
TSAFFVVQSVLTDEQFAQFGWRIPFVASALLVVIGLWIRLGVSDAPEFLEHKESGNVRKQ
PLWEVVTRHPRVLLVTIGLRLAQNSVYYLITVYMLTYLADQRGDSTAGITAVMIASAIGL
VTGPFWGWVSDRLGRRTVTLGGIIGIGVFGWIFFAFLDNGPLILLPIIVVLGMNLAHDAV
YGPQAAWFAEQFPIEVRYSGVNMGYQLGTVIGGGIMPMVAALLFVAGGSTPWLICAYLTL
LCVLSGIAALAAHDPARAEALARRTDPGPAAAADSAEDPAADPAADSVATEVAAPAAADP
HRPIQETSH
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory